Carcinogenesis · 2000 · 38 citations · 26 references
MedicinePharmacologyToxicologyCancer PharmacologyCarcinogenesisNeoplasiaAngiogenesisAngiogenesis In CancerAnimal Cell CultureChemical CarcinogenesisGenotoxic CarcinogenesisHormone-related CarcinogenesisCarcinogenic ResponseEndocrine CarcinogenesisEstrogen MetabolitesEstrogen-dependent CarcinogenesisHormonal CarcinogenesisMechanisms Of CarcinogenicityMicrotubule AbnormalitiesMicrotubule Assembly Disruption
2-methoxyestradiol (2-MeOE(2)) is an endogenous metabolite of 17beta-estradiol and a proposed inhibitor of tumor growth and angiogenesis. However, 2-MeOE(2) is also an inhibitor of microtubule assembly and other microtubule inhibitors, e.g. colcemid and diethylstilbestrol, induce aneuploidy and cell transformation in cultured mammalian cells. To assess the in vitro carcinogenicity and related activity of 2-MeOE(2), the abilities of this metabolite to induce cell transformation and genetic effects were studied simultaneously using Syrian hamster embryo (SHE) fibroblasts. Growth of these cells was reduced by treatment with 2-MeOE(2) at 0.1-1.0 microg/ml in a concentration-dependent manner. Treatment of SHE cells with 2-MeOE(2) at 0.3 or 1.0 microg/ml for 2-48 h also resulted in a concentration- and treatment time-related increase in the mitotic index and the percentage of multinucleated cells. Treatment with 2-MeOE(2) at 0.1-1.0 microg/ml for 48 h induced a statistically significant increase in the frequencies of morphological transformation of SHE cells in a concentration-dependent manner. A statistically significant increase in the frequencies of somatic mutations at the Na(+)/K(+) ATPase or hprt locus was also observed in cells treated with 2-MeOE(2) for 48 h at 0.1 or 0.3 microg/ml, respectively. Treatment of SHE cells with 2-MeOE(2) at 0.3 or 1.0 microg/ml for 24 h induced chromosome aberrations, mainly breaks, exchanges and chromosome pulverization. The incidence of chromosome aberrations was not affected by co-treatment with alpha-naphthoflavone, an inhibitor of 2-hydroxylase that inhibits oxidative conversion of 2-MeOE(2) to 2-hydroxyestradiol, but the incidence was slightly increased by co-treatment with L-ascorbic acid. Numerical chromosomal changes in the near diploid range and in the tetraploid and near tetraploid ranges were also detected in 2-MeOE(2)-treated cells. These findings indicate that 2-MeOE(2) has cell transforming and genotoxic activities in cultured mammalian cells and potential carcinogenic activity.
26
Chemical Mutagens. Principles and Methods for Their Detection.
Annals of Internal Medicine · 1974 · 1.5K citations
Pharmacy, Microbiology, Toxicology +17
Robert J. D’Amato, C. Michael Lin, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 409 citations
Carcinogenicity of catechol estrogens in Syrian hamsters
Joachim G. Liehr, Fang Wan-Fen, David A. Sirbasku et al. · Journal of Steroid Biochemistry · 1986 · 357 citations
Pharmacy, Endocrinology, Toxicology +12